Balyasny Asset Management’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-383,948
| Closed | -$7.24M | – | 1483 |
|
|
2019
Q3 | $7.24M | Buy |
+383,948
| New | +$7.24M | 0.05% | 429 |
|
|
2019
Q2 | – | Sell |
-106,682
| Closed | -$1.46M | – | 1661 |
|
|
2019
Q1 | $1.46M | Buy |
106,682
+81,381
| +322% | +$1.11M | 0.01% | 812 |
|
|
2018
Q4 | $259K | Buy |
+25,301
| New | +$259K | ﹤0.01% | 1157 |
|
|
2018
Q2 | – | Sell |
-54,349
| Closed | -$690K | – | 2077 |
|
|
2018
Q1 | $690K | Sell |
54,349
-552,946
| -91% | -$7.02M | ﹤0.01% | 1160 |
|
|
2017
Q4 | $6.95M | Buy |
607,295
+585,421
| +2,676% | +$6.7M | 0.02% | 630 |
|
|
2017
Q3 | $268K | Buy |
+21,874
| New | +$268K | ﹤0.01% | 1380 |
|